During Market hours Yesterday — (Thursday – 30.12.2021):
- The Dow (Symbol: DIA) went down 0.21%. The S&P 500 (Symbol: SPY) lost 0.28% and the Nasdaq (Symbol: QQQ) dropped 0.30%.
- Biogen (Symbol: BIIB) — Shares of Biogen slid 7% after Samsung denied a report in South Korean media that it was in talks to buy Biogen. The biotechnology stock had surged 9.5% on Wednesday on the report.
- DiDi Global (Symbol: DIDI) — The stock jumped 5.8% despite the company reporting a 1.7% decline in third-quarter revenue and a loss of $4.7 billion. Investors bought the dip in the Chinese ride-hailing company, which slid 8.2% Wednesday. It has also seen declines in 12 of the last 15 trading days.
- RR Donnelley & Sons (Symbol: RRD) — The commercial printing stock rose 5.5% after the company received a non-binding acquisition proposal at $11 per share in cash. The unsolicited offer comes two weeks after R.R. Donnelley agreed to be bought by affiliates of Chatham Asset Management, its largest shareholder, for $10.85 per share.
- Virgin Galactic (Symbol: SPCE) — Shares of the space travel company rose 6% as Virgin Orbit, its satellite-launching spin-off, geared up to begin trading Thursday on the Nasdaq, following an approved merger earlier this week with the blank-check company NextGen Acquisition Corp.
- Micron Technology (Symbol: MU) — The semiconductor stock dipped 2.3% after the company warned of production delays due to new Covid shutdowns in Xi’an, China. Micron said in a blog post that additional restrictions by the local government “may be increasingly difficult to mitigate.”
- ViacomCBS (Symbol: VIAC) — Shares of the media giant rose 3.7% and were among the top gainers in the S&P 500 on Thursday. The rise followed a Financial Times report Wednesday that U.S. video streamers are set to spend $115 billion on content in 2022.
During Premarket hours today – (Friday – 31.12.2021):
- Pfizer (Symbol: PFE) — British regulators have approved the use of Paxlovid – the drug maker’s Covid-19 antiviral pill – for people over 18 with mild to moderate illness.
- Peloton (Symbol: PTON) — The fitness equipment maker slid 1.3% in premarket action after JMP Securities downgraded the stock to “market perform” from “market outperform.” JMP cites declining website visits and page views.
- Lexicon Pharmaceuticals (Symbol: LXRX) — The drug maker’s shares surged 6.5% in premarket trading after it submitted a new drug application to the FDA for its heart drug sotagliflozin, which is designed to reduce the risk of heart failure in diabetic patients.
*Any information contained in this article, including any information contained in external third party links, if any, is solely for informational purposes and does not contain, or should not be construed as containing, investment advice or an investment recommendation, or, an offer of or solicitation for any transactions in financial instruments. Past performance does not guarantee or predict future performance. Colmex Pro Ltd does not take into account your personal investment objectives or financial situation and makes no representation, and assumes no liability to the accuracy or completeness of the information provided, nor for any loss arising from any investment based on presented information.